Back to top

Biocept, Inc. (BIOC) Soars: Stock Adds 9.8% in Session

Read MoreHide Full Article

Biocept, Inc. was a big mover last session, as the company saw its shares rise more than 9% on Friday. The move came on solid volume too with far more shares changing hands than in a normal session.

The move came after the company entered into an agreement with Alliance Global FZ, LLC to market the former’s Target Selector liquid biopsy tests in the United Arab Emirates and other countries in the Middle East, North & Sub-Saharan Africa, and Southeast Asia region.

The company has not seen any estimate revisions in the past month, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Biocept currently has a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

Investors interested in the Medical Services industry may consider BioTelemetry, Inc. (BEAT - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BIOC going up? Or down? Predict to see what others think: Up or Down

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


BioTelemetry, Inc. (BEAT) - free report >>